FDA Investigator Vickie J Kanion
Vickie J Kanion has inspections in 10 countries as of 14 Nov 2023. Vickie J Kanion has collaborated with a combined 3518 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
147
Last Inspection Date:
14 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Taiwan,
United States of America,
Belgium,
Canada,
Poland,
China,
India,
Germany,
France,
Italy
Co-Investigator(s):
Allen F Hall,
Allen Jackson,
Andrew A Hoopes,
Anthony E Keller, RPh,
Arindam Dasgupta, PhD,
Ashley A Mutawakkil,
Barbara Janine Breithaupt,
Barbara L Rogolsky,
Betsy C Galliher,
Bonita S Chester,
Bonnie E Pierson,
Brenda C Hamilton,
Brent T Hall,
Brent W Higgs,
Brett R Havranek,
Brian R Cronenwett,
Byungja E Marciante,
Candace S Tucker,
Carl A Huffman, III,
Carl J Montgomery,
Carla J Lundi,
Carmen Y Fisher,
Charles R Bonapace, PhD,
Chilton L Ng,
Chris A Sack,
Christine I Shaw,
Claire M Minden,
Cody D Rickman,
Courtney R Bratina,
Cynthia L Evitt,
Cynthia M Goudeau,
Dana D Carter, SR DDS,
Danial S Hutchison,
Daniel R Hurt,
Darrah,
David J Eide,
David L Miser,
Dawn C Olenjack,
Debra L Boyd Seale,
Diane Hall,
Dina K West,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Eric C Nielsen,
Eric M Mueller, PharmD,
Eric T Huebler,
Erin C Dugan,
Farhana Khan,
Fenhong Song,
George C Amedro,
George Ivan Wey,
George J Flynn,
Geraldine D Sanders,
Gregory D Dixon,
Gretchen Lf Trendel,
Guerda Prephete,
Guerda Prophete,
Gwyn G Dickinson,
Holly L Miller,
Holly Sebastian,
Hugh M Mcclure, II,
Ingrid Y Johnson,
Ismael Olvera, IV,
Jacqueline A O'shaughnessy, PhD,
James D Planchon,
James M Kewley,
James R Montero,
Jane E Nelson,
Janet B Abt,
Janet Pulver,
Janete A Eaker,
Janete A Oliveira,
Jeffery L Sumter,
Jennifer A Jones,
Jennifer C Adams,
Jennifer L Sheehan,
Jennifer T Szymanski,
Jessica E Hensley,
Jessica L Peterson,
Joan A Loreng,
Joanne M Schlossin,
John A Iwen,
Johnson,
Johnsont,
Jonathan R Campos,
Jonathan S Helfgott,
Joseph G Kramer,
Joseph R Lambert,
Joshua R Hayes,
Joy P Matthias,
Judy Ellen Ciaraldi,
Julie N Vosilus,
Jyoti B Patel, PhD,
Kara A Scheibner, PhD,
Karen L Kosar,
Karen M Montgomery (KMM),
Katherine M Taylor,
Katherine Szestypalow,
Kathleen B Swat,
Kathleen J Close,
Kellia N Hicks,
Kelly D Moore,
Kevin A Beavers,
Kimberly A Dux,
Latonya M Mitchell,
Lauren M Lilly, PhD,
LCDR Matthew J Morrison,
Leeterry Moore,
Lewis K Antwi,
Li Hongpaul Yeh, PhD,
Linda F Murphy,
Linda R Kuchenthal,
Linda S Leja,
Linhart,
Lisa D Ellis,
Lisa L Flores,
Lisa L Gilliam,
Lori A Gioia,
Marijo B Kambere, PhD,
Marion D Wimberly, Jr,
Matthew A Walburger,
Matthew R Mcnew,
Matthew R Sleeter,
Megan M Kirk,
Melinda L Rice,
Melkamu Getie Kebtie, PhD,
Melva J Palmer,
Michael F Skelly, PhD,
Michael I Gorman,
Michael S Kopf,
Michele L Obert,
Michele Perry Williams,
Michele R Cromer,
Minerva Rogers,
Mohsen Rajabi Abhari, FDA,
Monique M Brooks,
Mpris Inspector,
Nancy G Schmidt,
Neira Acevedo Ramos,
Nicole J Conklin,
Nilufer M Tampal, PhD,
Paige E Shelborne,
Pamela L Vega,
Paranthaman Senthamaraikannan,
Patrick D Stone, MS,
Patrick L Wisor,
Paula J Bretz,
Rafeeq A Habeeb,
Rakhi B Shah,
Richard L Rutherford,
Rita K Kabaso,
Robert J Nesselhauf,
Robert L Lewis, Jr,
Robert R Wilson,
Rodney D Combs,
Ron R Pearson,
Ruben C Ayala, PharmD,
Samantha J Pinizzotto, D V M,
Sarah E Morris,
Satheesh Thomas,
Scott B Laufenberg,
Shanna R Haden,
Shayna L Desilva,
Shirley J Berryman,
Siv K Si,
Sripal R Mada, PhD,
Stacy C Foster,
Stacy C Hetz,
State Agency,
Stephen T Hansen,
Stuart W Russell,
Susanna E Ford, Analyst,
Tamara J Umscheid,
Tara K Carmody,
Tara L Greene,
Telicia R White,
Terrance L Thomas,
Thai T Duong,
Theressa B Smith,
Thomas K Dobbs,
Torrey M Ward,
Traci C Kelm,
Veronica Fuentes, MS,
Walsworth,
Warren J Lopicka,
Wayne D Mcgrath,
William F Lagud, Jr,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Yiyue Zhang (nmi), PhD,
Young M Choi, PhD,
Zachary A Bogorad
Vickie J Kanion's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more